(lp0
(dp1
S'contVal'
p2
Vhigh
p3
sS'drug2'
p4
NsS'drug1'
p5
NsS'objectUri'
p6
NsS'evidence'
p7
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/39
p8
sS'ddiPkMechanism'
p9
NsS'whoAnnotated'
p10
Vboycer
p11
sS'contraindication'
p12
NsS'researchStatementLabel'
p13
Vdiltiazem_increases_auc_triazolam
p14
sS'severity'
p15
NsS'label'
p16
Vdiltiazem increases the AUC of triazolam 
p17
sS'source'
p18
S'DIKB'
p19
sS'ddiPkEffect'
p20
Vhttp://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/increases_auc
p21
sS'precip'
p22
VDILTIAZEM
p23
sS'homepage'
p24
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb-evidence/diltiazem_increases_auc_triazolam.html
p25
sS'researchStatement'
p26
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Assertions/30
p27
sS'dateAnnotated'
p28
V07/02/2007 17:38:07\u000a
p29
sS'object'
p30
VTRIAZOLAM
p31
sS'objectURI'
p32
Vhttp://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00897
p33
sS'evidenceSource'
p34
Vhttp://www.ncbi.nlm.nih.gov/pubmed/8612379
p35
sS'precipURI'
p36
Vhttp://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB00343
p37
sS'evidenceStatement'
p38
V\u000aRoute of administration: oral\u000a\u000astudy duration: 1 day pretreatment with diltiazem given 3x/day @ 60mg PO. On day two .25mg triazolam was given PO\u000a\u000apopulation: 10 subjects, male: 3 female: 7\u000a\u000aages: 18-31\u000a\u000aAUC_i/AUC 0-time of measurement (17hrs): 36.0/12.7 = 2.835\u000a\u000aAUC_i/AUC 0 -inf: 47/13.9 = 3.381\u000a\u000a
p39
sS'precipUri'
p40
NsS'uri'
p41
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIObservations1
p42
sS'evidenceType'
p43
Vhttp://dbmi-icode-01.dbmi.pitt.edu/dikb-evidence/DIKB_evidence_ontology_v1.3.owl#EV_PK_DDI_RCT
p44
sS'numericVal'
p45
V2.835
p46
sS'precaution'
p47
Nsa.